Changes in serine metabolism have been linked to cancer, and active serine synthesis is likely necessary to support the processes that affect cancer, such as amino acid transport, nucleotide synthesis ...
Iksuda Therapeutics Ltd. disclosed the design of a novel, effective and safe antibody-drug conjugate (ADC), IKS-012, for the potential treatment of folate receptor α (FRα)-positive cancers.